Hochuekkito accelerates recovery from cisplatin induced-muscle atrophy accompanied by slow-twitch fiber-specific microRNA upregulation in mice
IntroductionCis-diamine-dichloro-platinum (II) (cisplatin) is a widely prescribed anticancer drug known to induce severe side effects, including skeletal muscle atrophy. As muscle atrophy negatively impacts the prognosis and survival of cancer patients, elucidation of its pathogenesis and developmen...
Saved in:
| Main Authors: | Hitomi Sekine, Chinami Matsumoto, Naoki Fujitsuka, Sachiko Mogami, Shunsuke Ohnishi, Hiroshi Takeda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1502563/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Protective Effects of Perch Essence Against Muscle Atrophy in Cancer Cachexia and Cisplatin Treatment
by: Shu-Lan Yeh, et al.
Published: (2025-02-01) -
Cisplatin‐Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions
by: Ko‐Chieh Huang, et al.
Published: (2025-06-01) -
Cisplatin and the Dissolution of Electrodes in Electrochemistry Experiments
by: Ross Milton, et al.
Published: (2025-02-01) -
Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01) -
Xenogeneic lymphocytic RNA stimulates skeletal muscle regeneration
by: N. V. Tishevskaya, et al.
Published: (2021-09-01)